Rare diseases
Investigational molecules
Locations
Back to Croatia257 clinical trials in Zagreb, Croatia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
CroatiaLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
CroatiaA study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity
CroatiaA study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.
CroatiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
CroatiaStudy of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration
CroatiaTesting Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia
CroatiaA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
CroatiaA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
CroatiaA Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness
CroatiaA Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema
CroatiaA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on autoimmune disorders encompass treatments for psoriatic arthritis, Sjögren's Syndrome, and systemic lupus erythematosus, evaluating novel therapeutic approaches for improved patient outcomes.
These trials aim to assess new biological medicines and their effectiveness in managing chronic inflammatory conditions.
Research initiatives targeting neurological conditions focus on multiple sclerosis and Alzheimer's disease-related psychosis, exploring innovative treatment approaches for better disease management.
Studies evaluate both established and emerging treatments to improve patient outcomes and quality of life.
Advanced cancer research programs examine treatments for lung cancer, leukemia, and thyroid cancer, investigating targeted therapies and combination treatments.
These trials focus on improving survival rates and developing more effective treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
